Crossmark

A validated and environmentally sustainable high-performance thin-layer chromatography method for the concurrent analysis of axitinib, pazopanib, crizotinib, ruxolitinib, and ibrutinib in bulk drug substances and pharmaceutical formulations

Crossref DOI link: https://doi.org/10.1007/s00764-025-00372-w

Published Online: 2025-08-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mohammed, Mohammad Abdul-Azim

Fouad, Marwa Ahmed

Mohammed aboelyazed, Ahmed

Yehia, Ali Mohamed

Mahmoud, Sally Tarek https://orcid.org/0000-0001-8741-8271
License Information

Text and Data Mining valid from 2025-08-18

Version of Record valid from 2025-08-18
More Information

Article History

Received: 11 September 2024

Accepted: 24 July 2025

First Online: 18 August 2025

Declarations

:

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below